Ralaniten triacetate (EPI-506), a precursor of Ralaniten, is a first-of-its-kind, orally active androgen receptor N-terminal structural domain (AR-NTD) inhibitor with anticancer activity and can be used to study prostate and breast cancer.
Molecular Weight:
521
Purity:
98.69%
CAS Number:
[1637573-04-6]
Formula:
C27H33ClO8
Target:
Androgen Receptor
T36375
* VAT and and shipping costs not included. Errors and price changes excepted